[ <sup>18</sup> F]Fluorodeoxyglucose position emission tomography for differential diagnosis of depressive cognitive impairment: incremental value compared with clinical diagnosis
[<sup>18</sup>F]FDG PET provides a significant incremental diagnostic value beyond the clinical diagnosis in depressive cognitive impairment. Thus, [<sup>18</sup>F]FDG PET should be considered in the diagnostic work-up of patients with mental disorders and cognitive impairment.
Authors
- Katharina Domschke (ORCID: https://orcid.org/0000-0002-2550-9132)
- Philipp T. Meyer (ORCID: https://orcid.org/0000-0001-8336-750X)
- Joachim Brumberg (ORCID: https://orcid.org/0000-0003-0959-4776)
- Ganna Blazhenets (ORCID: https://orcid.org/0000-0003-2419-7373)
- Lars Frings (ORCID: https://orcid.org/0000-0001-9377-8935)
- Marie Heibel
- Sabine Hellwig (ORCID: https://orcid.org/0000-0002-3074-2588)
- Nils Schroeter
Institutions
- University of Freiburg (DE)
- University Medical Center Freiburg (DE)
Publication Details
- Journal
- The British Journal of Psychiatry
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1192/bjp.2025.67
- Citations
- 1
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 1.47